The Life Science Sector Shifts Its Focus Quickly to Respond to the Coronavirus
If the coronavirus has proven anything, it is that size and impact are not necessarily correlated. A 125-nanometer parasite that cannot be seen with the naked eye, the COVID-19 virus has killed over 160,000 people globally and infected 2.4M people worldwide. It has exposed systemic vulnerabilities in national healthcare systems and marked the emergence of new global trends. In the life sciences sector, it merely reinforced an already existing trend characterized by increasing collaboration and more projects that rely on the collective contributions of various partners. Today, the sector is proving to be highly agile and primed for impact. Collaborations in the sector are taking place across countries, rival companies, and public and private organizations, with the single aim of putting an end to the COVID-19 pandemic.
Click HERE to read more.